Precocious puberty and unlicensed paediatric drugs for severe hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 24, Issue 8, 2009, Pages 2595-2598

  Bacchetta, Justine ^a,b   Plotton, Ingrid ^a,b   Ranchin, Bruno ^a   Vial, Thierry ^a   Nicolino, Marc ^a,b   Morel, Yves ^a,b   Cochat, Pierre ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Chronic kidney disease; Cinacalcet; Lanthanum; Precocious puberty; TCF2 mutation

Indexed keywords

ALFACALCIDOL; BICARBONATE; CALCIUM CARBONATE; CINACALCET; LANTHANUM CARBONATE; SEVELAMER; SEX HORMONE; T CELL FACTOR 2 PROTEIN; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; HYPERPARATHYROIDISM; IRON THERAPY; KIDNEY DYSPLASIA; LOW DRUG DOSE; MALE; NAUSEA; PENIS DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SIDE EFFECT; TESTICULAR ENLARGEMENT; VOMITING; WEIGHT REDUCTION;

CHILD, PRESCHOOL; DRUG APPROVAL; DRUG LABELING; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; HYPERPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; LANTHANUM; MALE; MUTATION; NAPHTHALENES; PUBERTY, PRECOCIOUS; TESTOSTERONE; TREATMENT OUTCOME;

EID: 67651095865     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp211     Document Type: Article

References (14)

1. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303
2. Kunz GJ, Klein KO, Clemons RD et al. Virilization of young children after topical androgen use by their parents. Pediatrics 2004; 114: 282-284
3. Yu YM, Punyasavatsu N, Elder D et al. Sexual development in a twoyear-old boy induced by topical exposure to testosterone. Pediatrics 1999; 104: e23
4. Lane PH. Puberty and chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 372-377
5. Nemeth EF, Heaton WH, Miller M et al. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther 2004; 308: 627-635
6. Dheu C, Ruhlmann A, Michallat A et al. Pediatric experience of cinacalcet. Pediatr Nephrol 2007; 22: 1483
7. Park Y, Lee J. Cinacalcet is effective in the treatment of refractory secondary hyperparathyroidism in children with chronic renal failure. Pediatr Nephrol 2007; 22: 1551
8. Muscheites J, Wigger M, Drueckler E et al. Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease. Pediatr Nephrol 2008; 23: 1823-1829
9. EMEA. European AssessmentReportMIMPARA. Available at: http://wwwemeaeuropaeu/humandocs/PFDs/EPAR/mimpara/12029804en6pdf
10. WHO-UMC. http://www.who-umc.org/graphics/4409.pdf
11. Chang W, Shoback D. Extracellular Ca2+-sensing receptors-an overview. Cell Calcium 2004; 35: 183-196
12. Ulinski T, Lescure S, Beaufils S et al. Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort. J Am Soc Nephrol 2006; 17: 497-503
13. Montoli A, Colussi G, Massa O et al. Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1 beta gene: description of a new family with associated liver involvement. Am J Kidney Dis 2002; 40: 397-402
14. Bingham C, Ellard S, Cole TR et al. Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations. Kidney Int 2002; 61: 1243-1251